Shares of Sernova Corp. (TSE:SVA - Get Free Report) reached a new 52-week low on Monday . The company traded as low as C$0.15 and last traded at C$0.16, with a volume of 4850 shares traded. The stock had previously closed at C$0.15.
Sernova Stock Down 2.6 %
The company has a debt-to-equity ratio of -4.40, a current ratio of 0.32 and a quick ratio of 18.11. The stock has a market capitalization of C$62.25 million, a price-to-earnings ratio of -1.79 and a beta of 1.35. The firm's fifty day moving average is C$0.19 and its 200-day moving average is C$0.22.
Sernova Company Profile
(
Get Free Report)
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.
Further Reading
Before you consider Sernova, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sernova wasn't on the list.
While Sernova currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
